Cencora Inc.
Cencora Inc. Announces $3.0 Billion Senior Notes Offering
Summary
On February 13, 2026, Cencora, Inc. announced the completion of its sale of $3.0 billion aggregate principal amount of Senior Notes due between 2029 and 2056. The proceeds from the offering will be used to repay a portion of the debt related to the acquisition of OneOncology and for general corporate purposes. The notes bear interest rates ranging from 3.950% to 5.650% per annum and mature at various dates. The offering was conducted under an existing shelf registration statement filed with the SEC. A news release regarding the offering is furnished as Exhibit 99.1.
Get alerts for COR
Be first to know when Cencora Inc. files with the SEC.
Filing Categories
Advertisement
About Cencora Inc.
Cencora Inc., formerly known as AmerisourceBergen Corporation, represents a pivotal entity in the global healthcare distribution and services sector. As a leading pharmaceutical sourcing and distribution services company, Cencora Inc. plays a critical role in ensuring the efficient supply of pharmaceutical products to a range of healthcare providers, including hospitals, pharmacies, and clinics. Its business model is centered on the seamless integration of logistics, consulting services, and the provision of innovative solutions aimed at improving pharmaceutical supply chain operations. Cencora Inc. impacts various segments of the healthcare industry by enhancing the availability and accessibility of healthcare products. Known for its global reach and extensive network of distribution centers, the company supports the delivery of critical medications and healthcare products across numerous geographies. Cencora Inc.'s significance in the market is underscored by its ability to partner with pharmaceutical manufacturers and healthcare providers to streamline processes, reduce costs, and improve patient outcomes. Headquartered in Conshohocken, Pennsylvania, Cencora Inc. remains a cornerstone of the healthcare distribution market, focusing on sustainability, innovation, and strategic collaborations.
Official SEC Documents
Advertisement